Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02641171 · ClinicalTrials.gov registry record
Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02641171: Clinical Trial study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT02641171 is a clinical trial that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02641171 was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This study evaluates the use of exhaled air analysis as tool to monitor the disease activity in Crohn's Disease (CD). This study is a validation of the previous findings. In this study the participant will be asked to donate exhaled air, blood samples and fecal samples. The breath samples will be used to measure various volatile metabolites in breath. The breath air will be next used to validate the previous findings. The blood samples will be used to define the origin of volatile metabolites in breath. Finally, the potential of exhaled breath analysis as non-invasive marker of diseases activity will be compared to established fecal calprotectin.
Primary Outcome
The exhaled air samples will be used to first validate the volatile compounds for disease activity in Crohn's Disease.
Interventions
- OTHER Specimen sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-10-04 |
Why NCT02641171 stopped before completion
NCT02641171 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Specimen sampling is the first listed.
NCT02641171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02641171 about?
NCT02641171 is a clinical study titled "Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort". This study evaluates the use of exhaled air analysis as tool to monitor the disease activity in Crohn's Disease (CD). This study is a validation of the previous findings. In this study the participant will be asked to donate exhaled air, blood samples and fecal samples. The breath samples will be us...
What is the current status of trial NCT02641171?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2015-12. Estimated completion is 2016-10-04.
What interventions are being tested in trial NCT02641171?
The interventions under investigation include: Specimen sampling (OTHER).
Who is sponsoring clinical trial NCT02641171?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia